[A2k] Fwd: CEWG WHO Final Report
carolina.rossini at gmail.com
Wed Apr 11 07:07:22 PDT 2012
(english follows below)
---------- Forwarded message ----------
From: Claudia Chamas <chamas at cdts.fiocruz.br>
Date: Mon, Apr 9, 2012 at 4:03 PM
Subject: CEWG WHO Final Report
To: Claudia Chamas <chamas at cdts.fiocruz.br>
Tenho a satisfação de lhes encaminhar em anexo o relatório final
do Consultative Expert Working Group on Research and Development: Financing
and Coordination (CEWG),
estabelecido pela Assembléia Mundial de Saúde, em 2010.
O CEWG analisou diversas propostas sobre financiamento e coordenação
de pesquisa em saúde para atender às necessidades dos países em
Entre várias recomendações, o Grupo propõe a abertura de negociações
para o estabelecimento de uma Convenção Global de Pesquisa e
Desenvolvimento em Saúde de efeito vinculante.
Abaixo segue a nota para a imprensa elaborada pela Organização Mundial de
Informações adicionais estão disponíveis no sítio <
O relatório será debatido pelos Estados-membros na próxima Assembléia
Mundial da Saúde, em maio de 2012.
Centro de Desenvolvimento Tecnológico em Saúde (CDTS)
Vice-Presidência de Produção e Inovação em Saúde
Fundação Oswaldo Cruz (Fiocruz)
Av Brasil, 4365, Casa Amarela sala 1
chamas at cdts.fiocruz.br
Nota para a Imprensa
New incentives needed to encourage health research and development for
Funding needed to stimulate health research
5 April 2012 | Geneva - New sources of funding are needed to stimulate
health research specifically for diseases that affect people in developing
countries, according to a report published today by an international expert
group convened by WHO.
Increased global commitment to funding health research
The Consultative Expert Working Group on Research and Development:
Financing and Coordination (CEWG) has called for increased global
commitment to funding and coordinating health research to meet the specific
needs of developing countries. The group proposes a package of changes that
includes utilizing open knowledge innovation and prizes as incentives,
mandatory government commitments, pooling of funding and an international
binding convention on global health research.
Intellectual property rights and sales do not provide enough incentive to
encourage investment on diseases that mainly affect people in developing
countries, says John-Arne Røttingen, CEWG chair. If the price of health
products continues to reflect the full cost of R&D products will never be
affordable for those that need them most. We therefore need to do two
things: to delink the cost of research from the price of the product, and
to develop mechanisms in addition to intellectual property rights to
incentivize research investment in these diseases.
Recommendations to improve global financing
The CEWG report Research and development to meet health needs in
developing countries: strengthening global financing and coordination
includes, among others, the following recommendations:
Research outputs that address health needs of developing countries
should be in the public domain or made available through open licensing.
Patent pools should be used to increase sharing of research results.
Pooled funding mechanisms should coordinate financial resources and
some of the funds should be used for capacity building in developing
countries including direct grants to companies that can help promote
WHO should play a central coordinating role in global health research.
Increased funding is needed from governments and philanthropic sources
in the light of market failures of private investments.
All countries should commit to spend at least 0.01% of gross domestic
product on research to develop health technologies for use in developing
Discussion on the recommendations will take place at the 65th World Health
Assembly (WHA) in May 2012.
Note to editors
In 2010, the CEWG was asked by the World Health Assembly to review and take
forward the work done by the previous Expert Working Group on Research and
Development: Coordination and Financing.
The work of the CEWG is linked to the Commission on Intellectual Property
Rights, Innovation and Public Health which was set up by WHO in 2003 when
Member States agreed at the World Health Assembly (WHA) to look at the
relationship between intellectual property, innovation and public health.
The Commission produced its report in 2006. In follow-up of the
recommendations of the Commissions report an intergovernmental working
group negotiated over two years and WHA adopted a Global Strategy and Plan
of Action on Public Health, Innovation and Intellectual Property (GSPA-PHI)
in 2008. Search for enhanced and sustainable financing for R&D for
treatments of diseases that predominantly affect developing countries was
an unfinished agenda of the GSPA-PHI which was first taken up by the Expert
Working Group in 2010 and then by a Consultative Expert Working Group which
has now produced this report.
The CEWG is made up of 21 regionally representative experts, nominated by
their governments and appointed by WHOs Director-General Dr Margaret Chan.
The group met three times in Geneva during 2011. In an effort to be
transparent and inclusive, the CEWG encouraged input from many different
stakeholders, held regional consultations and published all relevant
documents and meeting outcomes on the WHO website.
A progress report was discussed at the Executive Board of WHO in January
2012, and the report will be considered by the World Health Assembly in May
Senior Fellow at GPOPAI
University of Sao Paulo
+ 1 6176979389
*carolina.rossini at gmail.com*
More information about the A2k